The purpose of the study is to see if Injectafer® will work to reduce death, hospitalizations associated with heart failure and improve daily function when administered to treat heart failure with iron deficiency and reduced ejection fraction. This study is also being done to see if Injectafer® is safe as a treatment for people in heart failure with iron deficiency.